Grant✓ Small businesses may apply

High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

National Institutes of Health

Opportunity #: RFA-DA-25-024
Agency: National Institutes of Health
ALN (CFDA): 93.279
Status: posted
Posted: Aug 2, 2024
Closes: Mar 6, 2027
Funding instrument: Grant
Category: Education, Health
Cost sharing required: No

Who can apply

•Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
•Small businesses
•Native American tribal governments (Federally recognized)
•Native American tribal organizations (other than Federally recognized tribal governments)
•City or township governments
•Public and State controlled institutions of higher education
•Special district governments
•Private institutions of higher education
•Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
•State governments
•Public housing authorities/Indian housing authorities
•County governments
•Independent school districts
•For profit organizations other than small businesses
•Others (see text field entitled "Additional Information on Eligibility" for clarification)

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Synopsis

The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.

Contact

National Institutes of Health · grantsinfo@nih.gov

View full notice on Grants.gov ↗